Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 2286-2291, November 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hilf, R.
Right arrow Articles by Borman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hilf, R.
Right arrow Articles by Borman, A.

Effect of Hydroxyurea and Related Compounds on HMC Mammary Tumor Growth and Nucleic Acids in Fischer Rats1

Russell Hilf, Carlton Bell, Inge Michel, James J. Freeman and Aleck Borman

Squibb Institute for Medical Research, New Brunswick, New Jersey

Hydroxyurea is an effective compound in inhibiting the growth of a transplantable mammary tumor (HMC) in the Fischer rat, the inhibition being dose related and independent of the duration of treatment. Several compounds related to hydroxyurea were tested and compared to the parent compound. 1-Ethyl-1-hydroxyurea and 1-methyl-1-hydroxyurea are more effective than hydroxyurea in causing inhibition of neoplastic growth. The response of the HMC tumor to several other known anticancer agents was also investigated to help characterize this mammary carcinoma.

The effect of hydroxyurea and related compounds upon HMC tumor nucleic acid concentration was studied. The inhibition of neoplastic growth induced by these compounds resulted in an increase in the RNA/mg tumor and also a consistent increase in the RNA/DNA ratio. Nucleic acid analyses were also performed on HMC carcinoma from animals treated with other known antitumor agents. The data are discussed in reference to the proposed mechanism of action of hydroxyurea.

1 Work supported by Contract No. SA-43-ph-2395 from the Cancer Chemotherapy National Service Center, National Cancer Institute, NIH, Bethesda, Md.

Received 11/15/65. Accepted 5/24/66.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.